HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Heartflow, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$51.02+2.73 (+5.65%)

Close on Oct 19, 2026

Market cap: $4.41B
P/E (TTM): –
Dividend yield: –

Heartflow, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q2 2026 2026-06-30	TTM Q1 2026 2026-03-31	TTM FY 2025 2025-12-31	TTM Q3 2025 2025-09-30	TTM Q2 2025 2025-06-30	TTM Q1 2025 2025-03-31	TTM FY 2024 2024-12-31
Depreciation & Amortization	5.32	5.49	5.44	5.66	5.75	–	5.36
Stock-Based Compensation	24	18	14	11	9.60	9.98	10
Change in Accounts Receivable	-13	-7.48	-4.89	-4.36	-5.15	–	-3.85
Change in Accounts Payable	3.39	3.51	0.22	0.35	-0.31	–	-0.33
Operating Cash Flow	-52	-71	-54	-57	-65	–	-69
Capital Expenditures	-6.95	-5.81	-5.03	-3.46	-3.24	–	-4.36
Investing Cash Flow	-217	-239	-239	-3.46	-3.24	–	-4.36
Debt Repaid	–	–	-115	–	–	–	–
Financing Cash Flow	223	219	286	287	73	–	2.24
Foreign Exchange Rate Adjustments	0.39	0.69	0.19	0.49	-0.12	–	-0.27
Net Change in Cash	-46	-90	-6.36	227	4.85	–	-71
Free Cash Flow	-59	-77	-59	-61	-68	–	-73
Income Taxes Paid	–	–	0	–	–	–	–
Interest Paid	–	–	8.57	13	15	–	19

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 80.1%
Operating margin: -37.8%
Net margin: -55.8%
Return on equity, FY2025: 41.8%

Financial strength

Current ratio: 5.08
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 77.9%

Valuation

P/E ratio: –
Price to sales: 20.79
Price to book: 15.76
Dividend yield: –